Taken together, our results indicate that PTBP1 is a major determinant in the pathology of HML, where the levels of PTBP1 in a tissue controls the levels of mis‐splicing of mutant ISCU. The gene discussed is PTBP1; the disease is hereditary myopathy with lactic acidosis due to ISCU deficiency.